Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | GALK1 | P51570 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.37 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14849938 | 0.95 | KMT2A (0.38) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL20664933 | 0.81 | ALDH1A1 (0.46) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL23396287 | 0.79 | CYP1B1 (0.42) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL13716839 | 0.78 | MAPT (0.42) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL15267178 | 0.78 | ADORA3 (0.33) | KDM4EALDH1A1HSD17B10MAPTHTT | |
| SCHEMBL29297667 | 0.77 | FEN1 (0.41) | KMT2AMEN1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL12355076 | 0.76 | ADORA3 (0.33) | KDM4EADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL22182105 | 0.75 | TDP1 (0.57) | KDM4EALDH1A1MAPTHPGDNPC1 | |
| SCHEMBL17930255 | 0.73 | CYP1A2 (0.33) | KMT2AMEN1ALDH1A1HSD17B10AHR | |
| SCHEMBL17281122 | 0.70 | ALDH1A1 (0.46) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11649254-B2 | Compound, a display panel and an electronic device | Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) | 2023-05-16 | — | — | US | disclosed |
| WO-2018106200-A1 | ORIGINAL DRUG MOLECULES FOR THE TREATMENT OF PARASITIC AND NEOPLASTIC DISEASES AND METHODS FOR PREPARATION THEREOF | T.C MEDİPOL ÜNİVERSİTESİ (TR) | 2018-06-14 | — | — | WO | disclosed |
| US-20160340387-A1 | NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE | ALPHABETA AB (SE) | 2016-11-24 | — | — | US | disclosed |
| US-9399730-B2 | Wavelength conversion material as encapsulate for solar module systems to enhance solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-26 | — | — | US | disclosed |
| US-9394479-B2 | Wavelength conversion film having pressure sensitive adhesive layer to enhance solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9382424-B2 | Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| US-20160108310-A1 | WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES | NITTO DENKO CORPORATION (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20150041052-A1 | WAVELENGTH CONVERSION LAYER ON A GLASS PLATE TO ENHANCE SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20150041042-A1 | PRESSURE SENSITIVE ADHESIVE TYPE OF WAVELENGTH CONVERSION TAPE FOR ENHANCING SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20140311566-A1 | MICROSTRUCTURED WAVELENGTH CONVERSION FILMS FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2014-10-23 | — | — | US | disclosed |
| US-20130139868-A1 | WAVELENGTH CONVERSION MATERIAL AS ENCAPSULATE FOR SOLAR MODULE SYSTEMS TO ENHANCE SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20130089946-A1 | WAVELENGTH CONVERSION FILM HAVING PRESSURE SENSITIVE ADHESIVE LAYER TO ENHANCE SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-03-28 | — | — | US | disclosed |
| US-7385064-B1 | Catalysts for use in enantioselective synthesis | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2008-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340387-A1 | NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE | APP, BACE1, PSEN1 | KMT2A 4629/4885MEN1 3447/4885KDM4E 4836/4885 |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | SUN2, NES, CRY1 | KMT2A 645/4885MEN1 970/4885KDM4E 983/4885 |
| US-11649254-B2 | Compound, a display panel and an electronic device | TEAD2, OCIAD2, TEAD4 | KMT2A 3001/4885MEN1 4643/4885KDM4E 3038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.